Article Information
History
- September 6, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Anne C. Moore1,
- Emery G. Dora2,
- Nadine Peinovich2,
- Kiersten P. Tucker2,
- Karen Lin2,
- Mario Cortese2 and
- Sean N. Tucker2,*
- 1School of Biochemistry and Cell Biology, University College Cork, Cork, Ireland
- 2Vaxart, Inc. South San Francisco, CA, USA
- ↵*Corresponding author. Dr. Sean Tucker, Chief Scientist Officer, Vaxart, Inc. stucker{at}vaxart.com
Posted September 06, 2020.
Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection
